Reneo Pharmaceuticals (RPHM) Stock Forecast & Price Target → Massive Crisis Looming — Protect Your Savings Now (From Weiss Ratings) (Ad) Free RPHM Stock Alerts $1.64 -0.03 (-1.51%) (As of 01:21 PM ET) Add Compare Share Share Analyst ForecastsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Reneo Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)How MarketBeat Calculates Price Target and Consensus RatingMarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating ReduceBased on 8 Analyst Ratings Consensus Price Target $11.01573.55% UpsideHigh Forecast$35.55Average Forecast$11.01Low Forecast$1.50 TypeCurrent Forecast6/18/23 to 6/17/241 Month Ago5/19/23 to 5/18/243 Months Ago3/20/23 to 3/19/241 Year Ago6/18/22 to 6/18/23Consensus RatingReduceReduceReduceBuyStrong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)2 Buy rating(s)Hold7 Hold rating(s)7 Hold rating(s)7 Hold rating(s)0 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$11.01$11.01$18.14$28.00Forecasted Upside573.55% Upside445.95% Upside533.07% Upside654.72% Upside Get Reneo Pharmaceuticals Upgrade and Downgrade Alerts Sign-up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address Ad Weiss RatingsMassive Crisis Looming — Protect Your Savings NowToday, Dr. Weiss is coming forward with a new warning, Only this time, it's not about the stock market, inflation, or recession … This time, it's about your financial freedom.Click here to learn how to prepare before it's too late. RPHM Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History RPHM Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Reneo Pharmaceuticals Stock vs. The CompetitionTypeReneo PharmaceuticalsMedical CompaniesS&P 500Consensus Rating Score1.882.702.50Consensus RatingReduceModerate BuyHoldPredicted Upside575.61% Upside764.17% Upside12.43% UpsideNews Sentiment RatingPositive NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame * Start Date * End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails5/14/2024HC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. KapoorSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$1.50-5.66%12/15/2023SVB LeerinkSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingOutperform ➝ Market Perform12/15/2023Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Hold12/14/2023LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Neutral12/14/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Underperform12/14/2023William BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. MinterSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform12/14/2023Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOverweight ➝ Neutral$25.00 ➝ $4.00+247.82%12/14/2023Robert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOutperform ➝ Neutral$28.00 ➝ $3.00+160.87%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:49 PM ET. RPHM Forecast - Frequently Asked Questions What is Reneo Pharmaceuticals's stock forecast and purchase recommendation? According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Reneo Pharmaceuticals is $11.01, with a high forecast of $35.55 and a low forecast of $1.50. The consensus rating for Reneo Pharmaceuticals stock is Reduce based on the current 1 sell rating and 7 hold ratings for RPHM. Learn more on RPHM's analyst rating history. Do Wall Street analysts like Reneo Pharmaceuticals more than its competitors? Analysts like Reneo Pharmaceuticals less than other "medical" companies. The consensus rating for Reneo Pharmaceuticals is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how RPHM compares to other companies. Does Reneo Pharmaceuticals's stock price have much upside? According to analysts, Reneo Pharmaceuticals's stock has a predicted upside of 445.95% based on their 12-month stock forecasts. What analysts cover Reneo Pharmaceuticals? Reneo Pharmaceuticals has been rated by research analysts at HC Wainwright in the past 90 days. Stock Forecasts and Research Tools Related Companies: Milestone Pharmaceuticals Stock Forecast Citius Pharmaceuticals Stock Forecast Akebia Therapeutics Stock Forecast Acrivon Therapeutics Stock Forecast Foghorn Therapeutics Stock Forecast Pyxis Oncology Stock Forecast Q32 Bio Stock Forecast Aldeyra Therapeutics Stock Forecast Nanobiotix Stock Forecast Design Therapeutics Stock Forecast Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:RPHM) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reneo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.